Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-13
2008-05-13
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S318000, C514S321000, C514S338000, C514S367000, C544S130000, C544S131000, C544S135000, C546S193000, C546S198000, C546S270100, C548S163000
Reexamination Certificate
active
07371748
ABSTRACT:
This invention relates to compounds of formula IwhereinR1and R2are defined herein, or a pharmaceutically acceptable salt thereof.It has been found that the compounds of formula I are adenosine receptor ligands with good affinity to the A2A-receptor and a high selectivity to the A1- and A3receptors. These compounds are useful, inter alia, in treatment of Alzheimer's disease, depression, Parkinson's disease and ADHD.
REFERENCES:
patent: 6734179 (2004-05-01), Flohr et al.
patent: 6992083 (2006-01-01), Norcross
patent: WO 01/97786 (2001-12-01), None
patent: WO 03/045385 (2003-06-01), None
patent: WO 03/049741 (2003-06-01), None
patent: WO 03/053961 (2003-07-01), None
Flohr Alexander
Jakob-Roetne Roland
Norcross Roger David
Riemer Claus
Hoffman-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Saeed Kamal A.
Yao Gene J.
LandOfFree
Benzothiazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2781360